Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

More pre-exposure prophylaxis for rising HIV infection?

Barreiro P.

AIDS Rev. 2014 Apr-Jun;16(2):118-9. No abstract available.

PMID:
24984768
2.

HIV pre-exposure prophylaxis.

Morin SF, Yamey G, Rutherford GW.

BMJ. 2012 Aug 13;345:e5412. doi: 10.1136/bmj.e5412. No abstract available.

PMID:
22890030
3.

Intentions to prescribe preexposure prophylaxis are associated with self-efficacy and normative beliefs.

Sachdev DD, Stojanovski K, Liu AY, Buchbinder SP, Macalino GE.

Clin Infect Dis. 2014 Jun;58(12):1786-7. doi: 10.1093/cid/ciu229. No abstract available.

4.

Reply to Sachdev et al.

Karris MY, Beekmann SE, Mehta SR, Polgreen PM.

Clin Infect Dis. 2014 Jun;58(12):1788. doi: 10.1093/cid/ciu231. No abstract available.

5.

Mexico conference considers pre-exposure prophylaxis for AIDS.

Roehr B.

BMJ. 2008 Aug 14;337:a1278. doi: 10.1136/bmj.a1278. No abstract available.

PMID:
18703652
6.

AIDS research. FDA panel recommends anti-HIV drug for prevention.

Cohen J.

Science. 2012 May 18;336(6083):792. doi: 10.1126/science.336.6083.792. No abstract available.

PMID:
22605725
7.

The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK.

McCormack S, Fidler S, Fisher M; British HIV Association.; British Association for Sexual Health and HIV..

Int J STD AIDS. 2012 Jan;23(1):1-4. doi: 10.1258/ijsa.2011.051211. No abstract available.

PMID:
22362679
8.

Miriam Hospital launches new HIV prevention program: PrEP program offers daily pill that can help prevent HIV infection.

[No authors listed]

R I Med J (2013). 2014 Jan;97(1):57. No abstract available.

PMID:
24960871
9.

Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.

Coutinho B, Prasad R.

Am Fam Physician. 2013 Oct 15;88(8):535-40. Review. No abstract available.

10.

THOUGHTS ON PrEP--FROM THE FIRST PERSON CURED OF HIV.

Brown TR.

Posit Aware. 2015 Jan-Feb;27(1):44-5. No abstract available.

PMID:
26302586
11.

FDA approves first drug to prevent HIV infection.

Roehr B.

BMJ. 2012 Jul 17;345:e4879. doi: 10.1136/bmj.e4879. No abstract available.

PMID:
22807165
12.

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.

Blackwell CW.

Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Review.

PMID:
25140852
13.

Transmission. Company halts Truvada PrEP for women study.

[No authors listed]

AIDS Policy Law. 2011 Jun;26(7):1. No abstract available.

PMID:
21735622
14.

[New fixed combination for HIV therapy].

[No authors listed]

Krankenpfl J. 2005;43(4-6):95. German. No abstract available.

PMID:
16171046
15.

HIV prevention trial in women is abandoned after drugs show no impact on infection rates.

Roehr B.

BMJ. 2011 Apr 20;342:d2613. doi: 10.1136/bmj.d2613. No abstract available.

PMID:
21508055
16.

Uptake of PrEP for HIV slow among MSM.

Kirby T, Thornber-Dunwell M.

Lancet. 2014 Feb 1;383(9915):399-400. No abstract available.

PMID:
24494225
17.

Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.

[No authors listed]

Prescrire Int. 2013 Jul;22(140):178-81.

PMID:
23951592
18.

[Should pre-exposure prophylaxis be used to prevent HIV?].

Nau JY.

Rev Med Suisse. 2015 Mar 11;11(465):622-3. French. No abstract available.

PMID:
25946876
19.

[HIV preexposure prophylaxis].

Olczak A, Grabczewska E.

Przegl Epidemiol. 2012;66(1):79-82. Review. Polish.

20.

[PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].

Marcus U.

MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:42-4. German. No abstract available.

PMID:
23961656
Items per page

Supplemental Content

Support Center